Considering the higher prevalence of breast cancer in women with schizophrenia compared to the general population, monitoring prolactin concentrations when prescribing antipsychotics and incorporating aripiprazole to lower prolactin levels in patients with hyperprolactinemia should be considered, particularly in those with a family history of breast cancer. Here, PRL is linked to hyperprolactinemia.